Journal of the American Chemical Society
Article
7.12 (H-20, d, J = 8.3 Hz) and δH 7.09 (H-21, d, J = 8.3 Hz),
while those of the minor isomer could be identified at δH 7.35
(H-20, overlapped with other signals) and δH 7.28 (H-21, d, J =
8.1 Hz). The HMBC correlations H-20/C-18,C-24 and H-21/
C-23 observed for the major isomer, together with the
correlations H-20/C-18,C-22,C-24 and H-21/C-19,C-23 for
the minor isomer, were in full agreement with the presence of
protons at positions 20 and 21. Following these results, the
structure of the natural product haouamine B must be revised
from 2 to 34, displaying two hydroxyl groups at C-22 and C-23
and not at C-21 and C-23, as previously reported.1 This
reassignment points to a biosynthesis that could involve L-
DOPA, which is more in line with alkaloids than the resorcinol
pattern usually associated with type II polyketides.
AUTHOR INFORMATION
Corresponding Author
■
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
We thank the CIPSM for financial support. M.M. is grateful to
the Alexander von Humboldt Foundation for a postdoctoral
fellowship. We also thank Prof. Siegfried Waldvogel and Dr.
Axel Kirste for assistance with electrochemical experiments and
insightful discussions. Dr. Noah Burns is thanked for helpful
discussions.
REFERENCES
(1) Garrido, L.; Zubía, E.; Ortega, M. J.; Salva,
68, 293−299.
a
■
Scheme 8. Exposure of “Iso-haouamine B” (2)
́
J. J. Org. Chem. 2003,
(2) (a) Belostotskii, A. M. J. Org. Chem. 2008, 73, 5723−5731.
(b) Burns, N. Z.; Krylova, I. N.; Hannoush, R. N.; Baran, P. S. J. Am.
Chem. Soc. 2009, 131, 9172−9173.
(3) (a) Smith, N. D.; Hayashida, J.; Rawal, V. H. Org. Lett. 2005, 7,
4309−4312. (b) Jeong, J. H.; Weinreb, S. M. Org. Lett. 2006, 8, 2309−
2312. (c) Furstner, A.; Ackerstaff, J. Chem. Commun. 2008, 2870−
̈
2872. (d) Taniguchi, T.; Zaimoku, H.; Ishibashi, H. J. Org. Chem.
2009, 74, 2624−2626. (e) Fenster, E.; Fehl, C.; Aube,
́
J. Org. Lett.
2011, 13, 2614−2617.
(4) Wipf, P.; Furegati, M. Org. Lett. 2006, 8, 1901−1904.
(5) (a) Baran, P. S.; Burns, N. Z. J. Am. Chem. Soc. 2006, 128, 3908−
3909. (b) Burns, N. Z.; Baran, P. S. Angew. Chem., Int. Ed. 2008, 47,
205−208. (c) Burns, N. Z.; Jeessing, M.; Baran, P. S. Tetrahedron
2009, 65, 6600−6610.
a
(6) (a) Grundl, M. A.; Trauner, D. Org. Lett. 2006, 8, 23−25.
(b) Tanaka, T.; Inui, H.; Kida, H.; Kodama, T.; Okamoto, T.;
Takeshima, A.; Tachi, Y.; Morimoto, Y. Chem. Commun. 2011, 47,
2949−2951.
(a) K2CO3, MeOH, 71%.
(7) Kirste, A.; Schnakenburg, G.; Stecker, F.; Fischer, A.; Waldvogel,
S. R. Angew. Chem., Int. Ed. 2010, 49, 971−975.
With the structure of naturally occurring haouamine B
clarified, we turned to obtaining pure samples of a synthetic
member of the haouamine family, viz. compound 2. Hydrolysis
of acetate 32, mediated by potassium carbonate in methanol,
afforded “iso-haouamine B”, 2, as an amorphous solid (Scheme
8). To date, over 100 mg of this compound have been
prepared, making it available for extensive biological testing.
(8) Grundl, M. A.; Kaster, A.; Beaulieu, E. D.; Trauner, D. Org. Lett.
2006, 8, 5429−5432.
(9) Ross, A. J.; Lang, H. L.; Jackson, R. F. J. Org. Chem. 2010, 75,
245−248.
(10) Dauben, W. G.; Michno, D. M. J. Org. Chem. 1977, 42, 682−
685.
(11) So, R. C.; Ndonye, R.; Izmirian, D. P.; Richardson, S. K.;
Guerrera, R. L.; Howell, A. R. J. Org. Chem. 2004, 69, 3233−3235.
(12) Ku, H.-Y.; Jung, J.; Kim, S.-H.; Kim, H. Y.; Ahn, K. H.; Kim, S.-
G. Tetrahedron: Asymmetry 2006, 17, 1111−1115.
CONCLUSIONS
■
In summary, we have developed a concise, total synthesis of the
structure originally assigned to haouamine B. Our fast approach
to the core of the molecule allowed for the detailed
investigation of a hypothesized oxidative phenol coupling and
eventually led to the proposed structure of the alkaloid. The
true structure of haouamine B was revised in accord with our
findings and has been reassigned to the catechol 34. In
principle, our total synthesis could be adapted to reach 34, but
with limited time and resources we have decided to resist this
temptation and focus on the further evaluation of iso-
haouamine B (2). The biological activity of 2 and a number
of synthetic intermediates and derivatives is currently under
investigation and will be reported in due course.
(13) (a) Shimizu, S.; Ohori, K.; Arai, T.; Sasai, H.; Shibasaki, M. J.
Org. Chem. 1998, 63, 7547−7551. (b) Jiricek, J.; Blechert, S. J. Am.
Chem. Soc. 2004, 126, 3534−3538.
(14) Jensen, T.; Pedersen, H.; Bang-Andersen, B.; Madsen, R.;
Jørgensen, M. Angew. Chem., Int. Ed. 2008, 47, 888−890.
(15) (a) Srogl, J.; Allred, G. D.; Liebeskind, L. S. J. Am. Chem. Soc.
1997, 119, 12376−12377. (b) Furstner, A.; Funel, J. A.; Tremblay, M.;
Bouchez, L. C.; Nevado, C.; Waser, M.; Ackerstaff, J.; Stimson, C. C.
Chem. Commun. 2008, 2873−2875.
(16) (a) Mukaiyama, T.; Matsuo, J. I.; Kitagawa, H. Chem. Lett. 2000,
1250−1251. (b) Mukaiyama, T.; Matsuo, J. I.; Yanagisawa, M. Chem.
Lett. 2000, 1072−1073.
ASSOCIATED CONTENT
■
S
* Supporting Information
Experimental details and spectra of all new synthetic
compounds and of haouamine B peracetate (33). This material
E
dx.doi.org/10.1021/ja301326k | J. Am. Chem. Soc. XXXX, XXX, XXX−XXX